Global Interventional Pulmonology Market

Report ID : 1268 | Published : 2022-06-20 | Pages: | Format: PDF/EXCEL

The Global Interventional Pulmonology Market is estimated to reach over USD 6.47 billion by 2030, exhibiting a CAGR of 6.6 % during the forecast period. 

Interventional pulmonology uses non-surgical, minimally invasive procedures to diagnose and treat lung cancer, thoracic cancer, tracheal cancer, and other respiratory system problems. Endoscopic procedures are employed, which entail inserting an instrument into the human body to investigate and treat internal organs and tissues. Shortness of breath, coughing, and chest pain are just a few symptoms that interventional pulmonary medicine can help with. Interventional pulmonology is a relatively new field that has surged in popularity in the last decade. It employs sophisticated devices to detect and treat a wide range of lung disorders. In addition to pulmonologists, cardiothoracic surgeons do interventional pulmonology therapies on a frequent basis. During the forecast period, factors such as rising lung cancer awareness and rising healthcare expenditure for research and development activities are expected to fuel market growth. However, the market's growth would be restricted by the associated patient risk, high maintenance costs, and barriers to entry for new enterprises. Increased use of e-cigarettes, rising healthcare expenses, and improved training programs for interventional pulmonologists are all possibilities.

Market Segmentation:

The Interventional Pulmonology Market is segmented on the basis of indications, end-users and products. Based on indications, the market is segmented as COPD, Asthma, Lung Cancer, Tracheal & Bronchial Stenosis, and Other Indications. By end-users, the market is segmented into Hospitals and Ambulatory Surgical Centers, Diagnostic Centers and Specialty Clinics, and Other End-Users. By-products, the market is segmented into Bronchoscopes, Electromagnetic Navigation Bronchoscopy Systems, Pleuroscopes, Respiratory Endotherapy Devices,     Airway Stents, Pleural Catheters, Endobronchial Valves, and Bronchial Thermoplasty Systems.

Based on product, the respiratory endotherapy devices segment is accounted as a major contributor to the Interventional Pulmonology Market.

In 2021, the worldwide interventional pulmonology market was led by respiratory endotherapy devices and is projected to continue over the forecast period. Bronchoscopic and endoscopic diagnostics and surgery are performed using respiratory endotherapy equipment. Bias forceps, cytology brushes, aspiration needles, electrosurgery snares, foreign body removal tools, guide sheaths, and other similar devices used in endotherapy procedures include biopsy forceps, cytology brushes, aspiration needles, electrosurgery snares, and foreign body removal tools, guide sheaths, and other similar devices used in respiratory endotherapy procedures.

Asthama segment witnessed growth at a rapid rate

In 2021, the asthma category accounted for the majority of the global interventional pulmonology market. Asthma affects people of any age, but children are the most affected. Recurrent bouts of dyspnea and wheezing characterize the condition, which varies in severity and frequency from person to person. It can happen to an individual at any time of day or night.

The North America Interventional Pulmonology Market holds a significant revenue share in the region.

North America, Europe, Latin America, Asia Pacific, the Middle East and Africa make up the worldwide interventional pulmonology market. North America is estimated to hold the highest share of the global interventional pulmonology market during the forecast period. However, due to an ageing population, changing sickness trends, and increased demands from healthcare facilities, the interventional pulmonology market in the Asia Pacific region is projected to expand substantially over the forecast period, making it a prominent region in the worldwide market.

Competitive Landscape

Some of the major key players in the Interventional Pulmonology Market are Argon Medical, Body Vision Medical Ltd., Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), CONMED Corporation, Cook Medical, ENDO-FLEX GmbH, Fujifilm Corporation, KARL STORZ SE & Co. KG,      Medtronic, Olympus Corporation, Pennine Healthcare, PENTAX Medical, Pulmonx Corporation, Richard Wolf GmbH, Rocket Medical plc., TAEWOONG, and Vygon.  In the interventional pulmonology area, companies like Olympus are continually releasing innovative products. In addition, many businesses are working hard to obtain regulatory approval for innovative procedures and interventions. Because of the market's consolidation, larger firms are focusing on acquiring smaller and medium-sized businesses.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Interventional Pulmonology Market Snapshot

Chapter 4. Global Interventional Pulmonology Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Key Trends in the Market

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. COVID 19 Impact Analysis

Chapter 5. Interventional Pulmonology Market Segmentation 1: By Indications Estimates & Trend Analysis

5.1. By Indications & Market Share, 2020 & 2030

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Indications:

5.2.1. COPD

5.2.2. Asthma

5.2.3. Lung Cancer

5.2.4. Tracheal & Bronchial Stenosis

5.2.5. Other Indications

Chapter 6. Interventional Pulmonology Market Segmentation 2: By End-Users Estimates & Trend Analysis

6.1. By End-Users & Market Share, 2020 & 2030

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:

6.2.1. Hospitals And Ambulatory Surgical Centers

6.2.2. Diagnostic Centers and Specialty Clinics

6.2.3. Other End-Users

Chapter 7. Interventional Pulmonology Market Segmentation 4: By Products Estimates & Trend Analysis

7.1. By Products Analysis & Market Share, 2020 & 2030

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Products:

7.2.1. Bronchoscopes

7.2.1.1.  Flexible Bronchoscopes

7.2.1.2.  Endobronchial Ultrasound Bronchoscopes (EBUS)

7.2.2. Electromagnetic Navigation Bronchoscopy Systems

7.2.3. Pleuroscopes

7.2.4. Respiratory Endotherapy Devices

7.2.4.1.  Aspiration Needles

7.2.4.2.  Biopsy Forceps

7.2.4.3.  Biopsy Brush

7.2.4.4.  Biopsy Needles

7.2.4.5.  Catheter

7.2.4.6.  Pulmonary Catheter

7.2.4.7.  Balloon Dilatation Catheter

7.2.4.8.  Others

7.2.5. Airway Stents

7.2.6. Pleural Catheters

7.2.7. Endobronchial Valves

7.2.8. Bronchial Thermoplasty Systems

Chapter 8. Interventional Pulmonology Market Segmentation 5: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Indications, 2020-2030

8.1.2. North America Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2020-2030

8.1.3. North America Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

8.1.4. North America Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2030

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) By Indications, 2020-2030

8.2.2. Europe Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2020-2030

8.2.3. Europe Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

8.2.4. Europe Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) By Indications, 2020-2030

8.3.2. Asia Pacific Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2020-2030

8.3.3. Asia Pacific Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

8.3.4. Asia Pacific Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) By Indications, (US$ Million) 2020-2030

8.4.2. Latin America Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2020-2030

8.4.3. Latin America Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2020-2030

8.4.4. Latin America Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA revenue Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) By Indications, (US$ Million) 2020-2030

8.5.2. MEA Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2020-2030

8.5.3. MEA revenue Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2020-2030

8.5.4. MEA revenue Interventional Pulmonology Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

8.5.4.1. South Africa

8.5.4.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Argon Medical

9.2.2. Body Vision Medical Ltd.

9.2.3. Boston Scientific Corporation

9.2.4. C. R. Bard, Inc. (Becton, Dickinson and Company)

9.2.5. CONMED Corporation

9.2.6. Cook Medical

9.2.7. ENDO-FLEX GmbH

9.2.8. Fujifilm Corporation

9.2.9. KARL STORZ SE & Co. KG

9.2.10. Medtronic

9.2.11. Olympus Corporation

9.2.12. Pennine Healthcare

9.2.13. PENTAX Medical

9.2.14. Pulmonx Corporation

9.2.15. Richard Wolf GmbH

9.2.16. Rocket Medical plc.

9.2.17. TAEWOONG

9.2.18. Vygon

9.2.19. List of Other Prominent Players

Segmentation of Interventional Pulmonology Market-

By Indications -

  • COPD
  • Asthma
  • Lung Cancer
  • Tracheal & Bronchial Stenosis
  • Other Indications

By End-Users-

  • Hospitals And Ambulatory Surgical Centers
  • Diagnostic Centers and Specialty Clinics
  • Other End-Users

By Products-

  • Bronchoscopes
  • Electromagnetic Navigation Bronchoscopy Systems
  • Pleuroscopes
  • Respiratory Endotherapy Devices
  • Airway Stents
  • Pleural Catheters
  • Endobronchial Valves
  • Bronchial Thermoplasty Systems

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Interventional Pulmonology Market?

USD 6.47 billion by 2030

exhibiting a CAGR of 6.6 % during the forecast period.

Our Clients